Latest News

  • 2016 Indicative Net Profit Increased by 13.5%

    Friday, February 17, 2017
    2016 Indicative Net Profit Increased by 13.5%

    Jakarta, February 17, 2017 – PT Kalbe Farma Tbk and Subsidiaries (“Kalbe” or “the Company”) today announced the Company’s indicative performance (unaudited) for the year 2016. Net sales grew by 8.3% to reach Rp 19,367 billion from Rp 17,887 billion in 2015

  • Kalbe Academia Supports Continuous Medical Education

    Indonesian Neurologist Forum

    Saturday, February 04, 2017
    Jakarta, 4 February 2017 - PT Kalbe Farma, Tbk (Kalbe) in collaboration with the Indonesian Neurologists' Association (PERDOSSI) holds an educaitonal event on neurology in the Grand Kalbe Akademia seminar and workshop series with the theme ”Indonesian Neurologist Forum”.
  • Kalbe Develops Biosimilar Factory

    Wednesday, January 18, 2017
    Kalbe Develops Biosimilar Factory

    Cikarang, 18 January 2017 – PT Kalbe Farma Tbk (Kalbe) today showed the progress of the biosimilar factory of PT Kalbio Global Medika which is located at Cikarang to the Chairperson of Food and Drugs Administration Body (BPOM), Dr. Ir. Penny K. Lukito, MCP.

  • Kalbe Holds the Dr. Boenjamin Setiawan Lecture Series On

    Anti Ageing Revolution through Stem Cell

    Monday, November 28, 2016

    Surabaya, 15 October 2016 – PT Kalbe Farma Tbk (Kalbe) today holds the health Education program for physicians, lecturers, and students of the Faculty of Medicine of University of Airlangga, Surabaya.   The program, titled dr. Boenjamin Setiawan Distinguished Lecture Series (DBSDLS) holds the theme: "Anti Ageing Revolution through Stem Cell" with speakers consisting of  dr.  Ferdiansyah, SpOT(K) from the Faculty of Medicine of Universitas Airlangga, Dr. dr.  Cita Rosita Sigit Prakoeswa, SpKK(K), FINSDV, FAADV  from the Faculty of Medicine Universitas Airlangga and Yuyus Kusnadi, PhD  from the Stem Cell and Cancer Institute.    

  • Maintaining Stable Growth and Margin

    Monday, October 31, 2016
    Maintaining Stable Growth and Margin

    Jakarta, October 31, 2016 – PT Kalbe Farma Tbk and Subsidiaries (“Kalbe” or “the Company”) today announced its third quarter 2016 results. Net sales grew by 9.5% to reach Rp 14,376 billion from Rp 13,128 billion in the same period in 2015.
RSS
12345Last
agario - kisaltmasi - diyet - ilahi dinle - film izle - cuma mesajlari - sarki sozleri - sarki sozleri - youtube